Omakase attended the II National Symposium on Biosimilars organised by Biosim
Omakase attended the II National Symposium on Biosimilars, held in Madrid on the [...]
2017 Budgetary Provision Proposal for Orphan Drugs in Spain
The Spanish Socialist Party representatives have recently presented a formal req [...]
“The Best Ideas of 2016” Award in the category of Research and Pharmacology
Omakase Consulting, leading company in Multicriteria Decision Analysis (MCDA) wa [...]
Omakase Consulting Awarded “The Best Ideas of 2016”
The idea of Multicriteria Decision Analysis (MCDA) of Omakase Consulting has bee [...]
Collaboration Agreement for Patients in the Cross Borders between Valencia and Aragon
Collaboration agreement between the Spanish Valencian and Aragon Autonomous r [...]
MCDA Training for Healthcare Professionals in Portugal
On 23rd November Omakase Consulting conducted a training workshop on MCDA at INF [...]
Debate focused on P&R, Protocol Armonisation and Prescription
An important initiative, led by Dr Toni Gilabert from CatSalut (Catalonian Regio [...]
Public Preferences MCDA application
Public preferences MCDA application to rank unmet healthcare needs; A very inter [...]
Orphan Drugs Evaluation and MCDA
A Spanish public report on orphan drugs published by the Institute of Health Car [...]
MCDA Seminar for ASEBIO
On Nov. 8th, 2016, Omakase Consulting has conducted a specific seminar about MCD [...]